Jonathan Javitch
Chief, Division of Molecular Therapeutics · New York Presbyterian Hospital
Credentials: · · ·
History
PresentDivision of Molecular Therapeutics · New York Presbyterian Hospital
- Present
Lieber Center for Schizophrenia Research and Treatment · New York Presbyterian Hospital
- 1986–1990
Research
Proceedings of the National Academy of Sciences of the United States of America · 1985 · First of 4 authors · 1,176 citations
Structure of the human dopamine D3 receptor in complex with a D2/D3 selective antagonist
Science · 2010 · 954 citations
Functional selectivity and classical concepts of quantitative pharmacology
Review · Journal of Pharmacology and Experimental Therapeutics · 2007 · 881 citations
9 papers · 2 as a fellow
7 papers
6 papers
- HW
4 papers
- NG
4 papers
4 papers · 2 as a resident
Bo Feng
3 papers
3 papers
Grants
- 2023–2028
Impact of Metabotropic Glutamate Receptor Heteromerization on Signaling and Pharmacology
National Institute of Neurological Disorders and Stroke · R01
Contact PI · $2.4M · New York State Psychiatric Institute Dba Research Foundation for Mental Hygiene, Inc
- 2024–2027
Pleiotropic Pathways of Extracellular Calcium Sensing
National Institute of Child Health and Human Development · R21
PI · $452.4K · Columbia University Health Sciences
- 1995–2027
Structure and Function of Dopamine Receptors
National Institute of Mental Health · R01
Contact PI · $12.8M · New York State Psychiatric Institute Dba Research Foundation for Mental Hygiene, Inc
- 2022–2025
Functional Validation of a Role for the Candidate Gene Ctr9 in Psychostimulant Action
National Institute on Drug Abuse · R21
Contact PI · $439.7K · New York State Psychiatric Institute Dba Research Foundation for Mental Hygiene, Inc